International Holding Co. PJSC

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: AEI000201014
AED
399.60
0.1 (0.03%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About International Holding Co. PJSC stock-summary
stock-summary
International Holding Co. PJSC
Pharmaceuticals & Biotechnology
International Holding Company PJSC, formerly International Fish Farming Holding Co PJSC, is a United Arab Emirates-based public joint stock company. The Company, together with its subsidiaries, is engaged in: the establishment, management and investment in aquaculture projects; the trading of fish and fish products; exporting, as well as preserving fish products and other sea living resources through cooling and freezing; buying, selling and dividing plots and real estates, as well as in the management, lease and development of real estate. Its primary activities are structured into the following segments: fish farming/ trading and processing; investment, as well as construction and contracting. The Company’s operations include: fish farming, aquaculture, distribution, sales and marketing, consultancy, and investments in aquaculture related projects through partnerships. The Company’s subsidiaries are: Alliance Foods Company LLC and Asmak Seafood Processing Co LLC, among others.
Company Coordinates stock-summary
Company Details
32619, P.O Box ABU DHABI None : None
stock-summary
Tel: 971 2 6448090
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Hamad Abdulla Rashed Obaid Al Shamsi
Non-Executive Independent Chairman of the Board
Mr. Nader Al Hammadi
Vice Chairman of the Board
Mr. Mohammed Al Muhairi
Member of the Board
Mr. Laith Al Fraih
Non-Executive Independent Member of the Board
Mr. Muammar Al Hadidi
Non-Executive Independent Member of the Board
Mr. Adel Al Nowais
Non-Executive Independent Member of the Board
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
27,519 Million
(Quarterly Results - Jun 2025)
Net Profit:
6,678 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

AED 877,635 Million (Large Cap)

stock-summary
P/E

46.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.36

stock-summary
Return on Equity

13.80%

stock-summary
Price to Book

6.28